| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.00B | 113.54B | 95.57B | 88.42B | 102.30B | 101.20B |
| Gross Profit | 25.67B | 22.71B | 21.25B | 21.07B | 22.69B | 21.89B |
| EBITDA | 10.93B | 11.85B | 9.59B | 8.89B | 7.66B | 12.02B |
| Net Income | 8.41B | 5.94B | 4.59B | 3.39B | 2.44B | 5.56B |
Balance Sheet | ||||||
| Total Assets | 114.91B | 101.29B | 79.75B | 82.13B | 89.61B | 92.73B |
| Cash, Cash Equivalents and Short-Term Investments | 11.58B | 11.53B | 3.63B | 7.37B | 8.61B | 9.48B |
| Total Debt | 31.16B | 31.50B | 24.57B | 25.99B | 29.59B | 26.95B |
| Total Liabilities | 116.32B | 103.76B | 81.13B | 84.26B | 92.64B | 94.31B |
| Stockholders Equity | -1.40B | -2.47B | -1.48B | -2.23B | -3.12B | -1.69B |
Cash Flow | ||||||
| Free Cash Flow | 9.44B | 8.55B | 1.87B | 5.92B | 562.00M | 7.51B |
| Operating Cash Flow | 12.47B | 11.19B | 4.52B | 8.68B | 3.56B | 10.31B |
| Investing Cash Flow | -3.03B | -2.06B | -2.21B | -2.78B | -3.02B | 1.31B |
| Financing Cash Flow | -5.66B | -1.46B | -5.82B | -7.09B | -1.63B | -16.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $204.78B | 30.61 | 91.94% | 0.18% | -18.43% | 242.76% | |
75 Outperform | $35.73B | 27.62 | 114.18% | 1.89% | 5.28% | 10.66% | |
75 Outperform | $210.93B | 86.06 | 916.38% | 1.02% | 28.92% | 55.56% | |
66 Neutral | $274.72B | 32.56 | -363.24% | 1.45% | 38.86% | ― | |
65 Neutral | $24.05B | 9.24 | -473.44% | 5.09% | 7.20% | 4.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |